Abstract:Tumor-associated macrophages (TAMs) represent a key factor in the tumor immune microenvironment (TME), exerting significant influence over tumor migration, invasion, immunosuppressive features, and drug resistance. Collagen triple helix repeat containing 1 (CTHRC1), a 30 KDa protein which was secreted during the tissue-repair process, is highly expressed in several malignant tumors, including colorectal cancer (CRC). Previous studies demonstrated that CTHRC1 expression in TAMs was positively correlated to M2 macrophage polarization and liver metastasis, while our discovery suggesting a novel mechanism that CTHRC1 secreted from cancer cell could indirectly interplay with TAMs. In this study, the high expression level of CTHRC1 was evaluated in CRC based on GEO and TCGA databases. Further, CTHRC1 was detected high in all stages of CRC patients by ELISA and was correlated to poor prognosis. Multispectral imaging of IHC demonstrated that M2 macrophage infiltration was increased accompanied with CTHRC1 enrichment, suggesting that CTHRC1 may have chemotactic effect on macrophages. In vitro, CTHRC1 could have chemotactic ability of macrophage in the presence of HT-29 cell line. Cytokine microarray revealed that CTHRC1 could up-regulate the CCL15 level of HT-29, pathway analysis demonstrated that CTHRC1 could regulate CCL15 by controlling the TGFβ activation and Smad phosphorylation level. In vivo, knocking down of CTHRC1 from CT-26 also inhibits tumor formation. In conclusion, CTHRC1 could promote the chemotactic ability of macrophages by up-regulating CCL15 via TGFβ/Smad pathway; additionally, a high level of CTHRC1 could promote macrophage's M2 polarization. This discovery may be related to tumor immune tolerance and tumor immunotherapy resistance in CRC. KEY MESSAGES: CTHRC1 promotes CRC progression by up-regulating CCL15 via TGF-β/Smad pathways to further recruit tumor-associated macrophages. By the means of autocrine or paracrine, CTHRC1 can indeed promote macrophage chemotaxis and enhance the infiltration of macrophages in tumor tissues but in the presence of tumor cells. CAFs were another source of CTHRC1, indicating CTHRC1 can infiltrate tumor islet as well as the stomal and be secreted from both tumor cells and CAFs. This study validated CTHRC1 as a potential immune therapy target CRC.

CCBE1 Promotes Tumor Lymphangiogenesis and is Negatively Regulated by TGFβ Signaling in Colorectal Cancer.

The YAP–TEAD4 Complex Promotes Tumor Lymphangiogenesis by Transcriptionally Upregulating CCBE1 in Colorectal Cancer

CCBE1 is a Prognostic Biomarker and Contributes to Prostate Cancer Cell Progression.

The promotion of non‐small cell lung cancer progression by collagen and calcium binding EGF domain 1 is mediated through the regulation of ERK/JNK/P38 phosphorylation by reactive oxygen species

Cthrc1 Promotes Human Colorectal Cancer Cell Proliferation and Invasiveness by Activating Wnt/Pcp Signaling

CCBE1 promotes mitochondrial fusion by inhibiting the TGFβ-DRP1 axis to prevent the progression of hepatocellular carcinoma

Clinical Significance of CCBE1 Expression in Lung Cancer

COL1A1 promotes metastasis in colorectal cancer by regulating the WNT/PCP pathway

CCDC113 promotes colorectal cancer tumorigenesis and metastasis via TGF-β signaling pathway

Connective Tissue Growth Factor Is Overexpressed in Esophageal Squamous Cell Carcinoma and Promotes Tumorigenicity through β-Catenin-T-cell Factor/Lef Signaling

CCBE1 promotes mitochondrial fusion by inhibiting the TGF3-DRP1 axis to prevent the progression of hepatocellular carcinoma

CTHRC1 Overexpression Predicts Poor Survival and Enhances Epithelial‐mesenchymal Transition in Colorectal Cancer

CTHRC1 promotes colorectal cancer progression by recruiting tumor-associated macrophages via up-regulation of CCL15

The Role of CTHRC1 in Regulation of Multiple Signaling and Tumor Progression and Metastasis

TBL1XR1 promotes lymphangiogenesis and lymphatic metastasis in esophageal squamous cell carcinoma.

TGFβ1I1 Suppressed Cell Migration and Invasion in Colorectal Cancer by Inhibiting the TGF-β Pathway and EMT Progress.

BTG1 Overexpression Might Promote Invasion and Metastasis of Colorectal Cancer via Decreasing Adhesion and Inducing Epithelial–Mesenchymal Transition

Upregulation of C/EBPα Contributes to Colorectal Cancer Growth, Metastasis and Indicates Poor Survival Outcome.

Chemokine (C-X-C Motif) Ligand 1 is Associated with Tumor Progression and Poor Prognosis in Patients with Colorectal Cancer

TGFβ Induced Factor Homeobox 1 Promotes Colorectal Cancer Development Through Activating Wnt/β-catenin Signaling.

Tumor bud-derived CCL5 recruits fibroblasts and promotes colorectal cancer progression via CCR5-SLC25A24 signaling